Mark P Chao Jison Hong Christian Kunder Laura Lester Stanley L Schrier Ravindra Majeti
10.1002/ajh.23791
Am J Hematol
2015 Jan;90(1):78-81.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/24942207/
Anemia, Hemolytic, Autoimmune / drug therapy Antibodies, Monoclonal, Humanized / therapeutic use Antibodies, Monoclonal, Murine-Derived / therapeutic use Churg-Strauss Syndrome / drug therapy Immunoglobulin M / immunology
Anemia, Hemolytic, Autoimmune / drug therapy Antibodies, Monoclonal, Humanized / therapeutic use Antibodies, Monoclonal, Murine-Derived / therapeutic use Churg-Strauss Syndrome / drug therapy Immunoglobulin M / immunology Case Reports Adult Anemia, Hemolytic, Autoimmune / blood Anemia, Hemolytic, Autoimmune / complications Anemia, Hemolytic, Autoimmune / immunology Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Murine-Derived / administration & dosage Autoantibodies / blood Churg-Strauss Syndrome / blood Churg-Strauss Syndrome / complications Churg-Strauss Syndrome / immunology Diagnosis, Differential Drug Therapy, Combination Female Hemoglobins / analysis Hemolysis / drug effects Humans Rituximab Treatment Outcome Antibodies, Monoclonal, Humanized Antibodies, Monoclonal, Murine-Derived Autoantibodies Hemoglobins Immunoglobulin M Rituximab eculizumab
PMC5435183
24942207
Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab
2015